Rare Disease in Oncology

Rare Oncology disease has a mandate to accost the recent challenges presented by rare cancers and diseases as well cancers that may be predominant in medically unreasonable populations. CCR investigators, both at the laboratory bench and in the clinic, are actively involved in this research studies.  In many cases, the knowledge CCR’s investigators gain from studying and treating rare cancer diseases and related disorders provides them with insights into the mechanisms that underlie other more common malignant syndromes.  It is very worthy consideration for oncologists to keep updated of the latest advancements in oncology, as changes in management of cancer are shown quite common. All eligible patients in whom cancer progresses and for whom no general of care treatment strategies are available should be enrolled in a clinical trial.

  • Pediatric Oncology
  • Blood Oncology
  • Merkel-cell carcinoma
  • Cancer and Pharmacology

Related Conference of Rare Disease in Oncology

May 10-11, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore
May 27-28, 2021

7th Rare Diseases and Orphan Drugs

Vienna, Austria
July 19-20, 2021

13th Global Infections Conference

Tokyo, Japan
September 06-07, 2021

11th World Congress on Rare Diseases and Orphan Drugs

Berlin, Germany
October 21-22, 2021

International Conference on Tropical Diseases and Cure

Zurich, Switzerland
November 22-23, 2021

3rd World Congress on Advancements in Tuberculosis and Lung Diseases

Singapore City, Singapore
February 07-08, 2022

9th International Congress on Infectious Diseases

Aberdeen, UK

Rare Disease in Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in